NUVL

Nuvalent, Inc

$123.50
Compare NUVL
Market Cap
$9.76B+61.9%
Revenue (TTM)
$0
Net Income (TTM)
$-478,973,890
EPS (TTM)
-6.05
Shares Out
79.13M
Open
$123.50
Previous Close
$123.50
Day Range
$123.44 – $123.56
52-Week Range
$71.13 – $123.69
Beta
1.15
Volume
1.65M
Avg Volume
1.65M
Analyst Rating
Buy
Exchange
NASDAQ NMS - GLOBAL MARKET

About NUVL

GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.

Related

News